The authors demonstrated inhibition of non-canonical NF-κB signaling in NIK-dependent MM cell lines whereas MM cell lines containing mutations that activate non-canonical NF-κB signaling independent of NIK, were not affected. Here, NFKB1 is linked to Miyoshi myopathy.